OpenURL Connection Search

Select item for more details and to access through your institution.

COMMENT: TRADEMARKS, TRADENAMES AND UNFAIR COMPETITION.
Published in:
American Business Law Journal, 1967, v. 5, n. 3, p. 338, doi. 10.1111/j.1744-1714.1967.tb00718.x
By:
- Wolk, Stuart R.
Publication type:
Article
Obesity-related cardiovascular disease: implications of obstructive sleep apnea.
Published in:
Diabetes, Obesity & Metabolism, 2006, v. 8, n. 3, p. 250, doi. 10.1111/j.1463-1326.2005.00508.x
By:
- Wolk, R.;
- Somers, V. K.
Publication type:
Article
The incidence of central nervous system leukemia in adults with acute leukemia.
Published in:
1974
By:
- Wolk, Richard W.;
- Masse, Serge R.;
- Conklin, Richard;
- Freireich, Emil J.;
- Wolk, R W;
- Masse, S R;
- Conklin, R;
- Freireich, E J
Publication type:
journal article
Pharmacokinetic, Pharmacodynamic, and Safety Profile of a New Cholesteryl Ester Transfer Protein Inhibitor in Healthy Human Subjects.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 86, n. 4, p. 430, doi. 10.1038/clpt.2009.120
By:
- Wolk, R.;
- Chen, D.;
- Clark, R. W.;
- Mancuso, J.;
- Barclay, P. L.
Publication type:
Article
Hypomagnesemia in heart failure with ventricular arrhythmias. Beneficial effects of magnesium supplementation.
Published in:
Journal of Internal Medicine, 2000, v. 247, n. 1, p. 78, doi. 10.1046/j.1365-2796.2000.00585.x
By:
- Ceremużyński, L.;
- Gębalska, J.;
- Wołk, R.;
- Makowska, E.
Publication type:
Article
Synthesis and Enzyme-Inhibition Studies of Phenylsemicarbazones derived from D-glucono-1,5-lactone and 2-acetamido-2-deoxy- D-glucono-1,5-lactone.
Published in:
Helvetica Chimica Acta, 1992, v. 75, n. 1, p. 323, doi. 10.1002/hlca.19920750129
By:
- Wolk, Diane R.;
- Vasella, Andrea;
- Schweikart, Fritz;
- Peter, Martin G.
Publication type:
Article
Quantitative Evaluations of Time-Course and Treatment Effects of Systemic Agents for Psoriasis: A Model-Based Meta-Analysis.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 6, p. 1006, doi. 10.1002/cpt.732
By:
- Checchio, T;
- Ahadieh, S;
- Gupta, P;
- Mandema, J;
- Puig, L;
- Wolk, R;
- Valdez, H;
- Tan, H;
- Krishnaswami, S;
- Tallman, A;
- Kaur, M;
- Ito, K
Publication type:
Article
Evaluating Dosage Optimality for Tofacitinib, an Oral Janus Kinase Inhibitor, in Plaque Psoriasis, and the Influence of Body Weight.
Published in:
CPT: Pharmacometrics & Systems Pharmacology, 2017, v. 6, n. 5, p. 322, doi. 10.1002/psp4.12182
By:
- Hutmacher, MM;
- Papp, K;
- Krishnaswami, S;
- Ito, K;
- Tan, H;
- Wolk, R;
- Valdez, H;
- Mebus, C;
- Rottinghaus, ST;
- Gupta, P
Publication type:
Article
Dose Response and Pharmacokinetics of Tofacitinib (CP-690,550), an Oral Janus Kinase Inhibitor, in the Treatment of Chronic Plaque Psoriasis.
Published in:
CPT: Pharmacometrics & Systems Pharmacology, 2013, v. 2, n. 5, p. 1, doi. 10.1038/psp.2013.22
By:
- H. Tan;
- Gupta, P.;
- Harness, J.;
- Wolk, R.;
- Chapel, S.;
- Menter, A.;
- Strober, B.;
- Langley, R. G.;
- Krishnaswami, S.;
- Papp, K. A.
Publication type:
Article
Left ventricular hypertrophy increases transepicardial dispersion of repolarisation in hypertensive patients: a differential effect on QTpeak and QTend dispersion.
Published in:
European Journal of Clinical Investigation, 2001, v. 31, n. 7, p. 563, doi. 10.1046/j.1365-2362.2001.00850.x
By:
- Wolk, R.;
- Mazurek, T.;
- Lusawa, T.;
- Wasek, W.;
- Rezler, J.
Publication type:
Article
Extrasystolic beats affect transmural electrical dispersion during programmed electrical....
Published in:
European Journal of Clinical Investigation, 2001, v. 31, n. 4, p. 293, doi. 10.1046/j.1365-2362.2001.00817.x
By:
- Wolk, R.;
- Stec, S.;
- Kulakowski, P.
Publication type:
Article
Effects of glucose-insulin-potassium infusion on QT dispersion in patients with acute myocardial infarction.
Published in:
2001
By:
- Wolk, Robert;
- Lusawa, Tomasz;
- Ceremuzynski, Leszek;
- Wolk, R;
- Lusawa, T;
- Ceremuzynski, L
Publication type:
journal article
Stability of imipenem and cilastatin sodium in total parenteral nutrient solution.
Published in:
1990
By:
- Zaccardelli, David S.;
- Sanders Krcmarik, Claudia;
- Wolk, Robert;
- Khalidi, Nabil;
- Zaccardelli, D S;
- Krcmarik, C S;
- Wolk, R;
- Khalidi, N
Publication type:
journal article
Arrhythmogenic mechanisms in left ventricular hypertrophy.
Published in:
EP: Europace, 2000, v. 2, n. 3, p. 216, doi. 10.1053/eupc.2000.0110
By:
- Wolk, R.
Publication type:
Article
Tofacitinib benefit‐risk profile in chronic plaque psoriasis.
Published in:
British Journal of Dermatology, 2019, v. 180, n. 1, p. e19, doi. 10.1111/bjd.17373
By:
- Strober, B.E.;
- Gottlieb, A.B.;
- Kerkhof, P.C.M.;
- Puig, L.;
- Bachelez, H.;
- Chouela, E.;
- Imafuku, S.;
- Thaçi, D.;
- Tan, H.;
- Valdez, H.;
- Gupta, P.;
- Kaur, M.;
- Frajzyngier, V.;
- Wolk, R.
Publication type:
Article
托法替布在慢性斑块型银屑病中的获益风险特征.
Published in:
British Journal of Dermatology, 2019, v. 180, n. 1, p. e32, doi. 10.1111/bjd.17387
By:
- Strober, B.E.;
- Gottlieb, A.B.;
- Kerkhof, P.C.M.;
- Puig, L.;
- Bachelez, H.;
- Chouela, E.;
- Imafuku, S.;
- Thaçi, D.;
- Tan, H.;
- Valdez, H.;
- Gupta, P.;
- Kaur, M.;
- Frajzyngier, V.;
- Wolk, R.
Publication type:
Article
Benefit–risk profile of tofacitinib in patients with moderate‐to‐severe chronic plaque psoriasis: pooled analysis across six clinical trials.
Published in:
British Journal of Dermatology, 2019, v. 180, n. 1, p. 67, doi. 10.1111/bjd.17149
By:
- Strober, B.E.;
- Tan, H.;
- Valdez, H.;
- Gupta, P.;
- Wolk, R.;
- Kaur, M.;
- Frajzyngier, V.;
- Gottlieb, A.B.;
- Kerkhof, P.C.M.;
- Puig, L.;
- Bachelez, H.;
- Chouela, E.;
- Imafuku, S.;
- Thaçi, D.
Publication type:
Article
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials.
Published in:
British Journal of Dermatology, 2015, v. 173, n. 4, p. 949, doi. 10.1111/bjd.14018
By:
- Papp, K.A.;
- MENter, M.A.;
- Abe, M.;
- Elewski, B.;
- Feldman, S.R.;
- Gottlieb, A.B.;
- Langley, R.;
- Luger, T.;
- Thaci, D.;
- Buonanno, M.;
- Gupta, P.;
- Proulx, J.;
- Lan, S.;
- Wolk, R.
Publication type:
Article
Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial.
Published in:
British Journal of Dermatology, 2015, v. 172, n. 5, p. 1395, doi. 10.1111/bjd.13551
By:
- Bissonnette, R.;
- Iversen, L.;
- Sofen, H.;
- Griffiths, C.E.M.;
- Foley, P.;
- Romiti, R.;
- Bachinsky, M.;
- Rottinghaus, S.T.;
- Tan, H.;
- Proulx, J.;
- Valdez, H.;
- Gupta, P.;
- Mallbris, L.;
- Wolk, R.
Publication type:
Article
Effect of tofacitinib, a Janus kinase inhibitor, on haematological parameters during 12 weeks of psoriasis treatment.
Published in:
British Journal of Dermatology, 2013, v. 169, n. 5, p. 992, doi. 10.1111/bjd.12517
By:
- Strober, B.;
- Buonanno, M.;
- Clark, J.D.;
- Kawabata, T.;
- Tan, H.;
- Wolk, R.;
- Valdez, H.;
- Langley, R.G.;
- Harness, J.;
- Menter, A.;
- Papp, K.
Publication type:
Article
Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study.
Published in:
British Journal of Dermatology, 2012, v. 167, n. 3, p. 668, doi. 10.1111/j.1365-2133.2012.11168.x
By:
- Papp, K.A.;
- Menter, A.;
- Strober, B.;
- Langley, R.G.;
- Buonanno, M.;
- Wolk, R.;
- Gupta, P.;
- Krishnaswami, S.;
- Tan, H.;
- Harness, J.A.
Publication type:
Article
Association between serum interleukin‐17A and clinical response to tofacitinib and etanercept in moderate to severe psoriasis.
Published in:
Clinical & Experimental Dermatology, 2018, v. 43, n. 7, p. 790, doi. 10.1111/ced.13561
By:
- Fitz, L.;
- Zhang, W.;
- Soderstrom, C.;
- Fraser, S.;
- Lee, J.;
- Quazi, A.;
- Wolk, R.;
- Mebus, C. A.;
- Valdez, H.;
- Berstein, G.
Publication type:
Article

Found: 22